Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Carlos De las Cuevas & Jose de Leon. (2020) Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics. Patient Preference and Adherence 14, pages 1823-1842.
Read now
Read now
Maria Ruiz-Iriondo, Karmele Salaberría, Rocio Polo-López, Álvaro Iruin & Enrique Echeburúa. (2020) Improving clinical symptoms, functioning, and quality of life in chronic schizophrenia with an integrated psychological therapy (IPT) plus emotional management training (EMT): A controlled clinical trial. Psychotherapy Research 30:8, pages 1026-1038.
Read now
Read now
Carlos De Las Cuevas & Jose de Leon. (2019) Development and validation of the Patient’s Health Belief Questionnaire on Psychiatric Treatment. Patient Preference and Adherence 13, pages 527-536.
Read now
Read now
Nazan Aydın, Hasan Mervan Aytaç, Esra Yazıcı, Doğan Yılmaz, Pınar Çetinay Aydın, Gökşen Yüksel Yalçın, Yücel Kadıoğlu, Cana Canbay, Merve Terzioğlu, Onur Şenol, Cavide Çakmak & Aysel Özer. (2019) Rediscovery of penicillin of psychiatry: haloperidol decanoate. Psychiatry and Clinical Psychopharmacology 29:3, pages 264-275.
Read now
Read now
Charles Ruetsch, Hyong Un & Heidi C Waters. (2018) Claims-based proxies of patient instability among commercially insured adults with schizophrenia. ClinicoEconomics and Outcomes Research 10, pages 259-267.
Read now
Read now
Carlos De las Cuevas, Jose de Leon, Wenceslao Peñate & Moisés Betancort. (2017) Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach. Patient Preference and Adherence 11, pages 681-690.
Read now
Read now
Kimberly M Shuler. (2014) Approaches to improve adherence to pharmacotherapy in patients with schizophrenia. Patient Preference and Adherence 8, pages 701-714.
Read now
Read now
Articles from other publishers (14)
Nan Dai, Bingjie Huang, Tianqi Gao, Yue Zheng, Chuan Shi, Chengcheng Pu & Xin Yu. (2023) Initial attitudes toward a drug predict medication adherence in first-episode patients with schizophrenia: a 1-year prospective study in China. BMC Psychiatry 23:1.
Crossref
Crossref
Jamie Light, Christine Ruh, Michael Ott, Christopher Banker, Drake Meaney, Fred Doloresco & Katia Noyes. (2022) The Effect of Pharmacy-Led Medication Reconciliation on Odds of Psychiatric Relapse at a Community Hospital. Journal of Pharmacy Practice, pages 089719002211371.
Crossref
Crossref
Chizimuzo T.C. Okoli, Amani Kappi, Tianyi Wang, Andrew Makowski & Andrew T. Cooley. (2021) The effect of long‐acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review and meta‐analysis. International Journal of Mental Health Nursing 31:3, pages 469-535.
Crossref
Crossref
Dulcinea Vega, Francisco J. Acosta & Pedro Saavedra. (2021) Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up study. Comprehensive Psychiatry 108, pages 152240.
Crossref
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M Kane & Christoph U Correll. (2021) Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies. The Lancet Psychiatry 8:5, pages 387-404.
Crossref
Crossref
Alexandra Burton, Kate Walters, Louise Marston & David Osborn. (2020) Is there an association between perceived social support and cardiovascular health behaviours in people with severe mental illnesses?. Social Psychiatry and Psychiatric Epidemiology 55:12, pages 1659-1669.
Crossref
Crossref
Dulcinea Vega, Francisco J Acosta & Pedro Saavedra. (2020) Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study. World Journal of Psychiatry 10:11, pages 260-271.
Crossref
Crossref
Lucie Kondrátová, Daniel König, Karolína Mladá & Petr Winkler. (2018) Correlates of Negative Attitudes towards Medication in People with Schizophrenia. Psychiatric Quarterly 90:1, pages 159-169.
Crossref
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Masahiro Nitta, Stefan Leucht, Mark Olfson, John M Kane & Christoph U Correll. (2018) Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies. Schizophrenia Bulletin 44:3, pages 603-619.
Crossref
Crossref
Mana K. Ali, Samantha M. Hack, Clayton H. Brown, Deborah Medoff, Lijuan Fang, Elizabeth A. Klingaman, Stephanie G. Park, Lisa B. Dixon & Julie A. Kreyenbuhl. (2017) Racial Differences in Mental Health Recovery among Veterans with Serious Mental Illness. Journal of Racial and Ethnic Health Disparities 5:2, pages 235-242.
Crossref
Crossref
A. El Ammouri & H. Kisra. (2017) Étude de l’observance thérapeutique chez une population de patients atteints de schizophrénie au Maroc. L'Encéphale 43:6, pages 522-527.
Crossref
Crossref
George Awad, Daisy Ng-Mak, Krithika Rajagopalan, Jay Hsu, Andrei Pikalov & Antony Loebel. (2016) Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia. BMC Psychiatry 16:1.
Crossref
Crossref
Ping-Tao Tseng, Yen-Wen Chen, Pao-Yen Lin, Kun-Yu Tu, Hung-Yu Wang, Yu-Shian Cheng, Yi-Chung Chang, Chih-Hua Chang, Weilun Chung & Ching-Kuan Wu. (2016) Significant treatment effect of adjunct music therapy to standard treatment on the positive, negative, and mood symptoms of schizophrenic patients: a meta-analysis. BMC Psychiatry 16:1.
Crossref
Crossref
Sarah C.E. Chapman & Rob Horne. (2013) Medication nonadherence and psychiatry. Current Opinion in Psychiatry 26:5, pages 446-452.
Crossref
Crossref